These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3301245)

  • 1. Maintenance therapy for prevention of recurrent peptic ulcers.
    Berardi RR; Savitsky ME; Nostrant TT
    Drug Intell Clin Pharm; 1987 Jun; 21(6):493-501. PubMed ID: 3301245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
    ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.
    Libeskind M
    Scand J Gastroenterol Suppl; 1983; 83():69-70. PubMed ID: 6356324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for the prevention of peptic ulcer recurrence.
    Piper DW
    Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The other option in peptic ulcer therapy.
    Halter F
    S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lansoprazole on peptic ulcers.
    Ohashi T; Sakata J; Haraguchi Y; Eto T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of duodenal ulcer recurrence.
    Strum WB
    Ann Intern Med; 1986 Nov; 105(5):757-61. PubMed ID: 2876669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD; Grant SM; Goa KL
    Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
    Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery.
    Lamothe PH; Rao E; Serra AJ; Castellano J; Woronick CL; McNicholas KW; Lemole GM
    Gastroenterology; 1991 Jun; 100(6):1515-20. PubMed ID: 2019357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.